SFX by Ex Libris Inc.

Title:	Sex- and strain-specific induction of renal tumors by ochratoxin A in rats correlates with DNA adduction
Source:	International Journal of Cancer [0020-7136] Castegnaro, Marcel yr:1998

Basic

Full text

Full text available via Wiley Online Library All Journals

Year:

Volume:

Issue:

Start Page:

Full text available via Wiley Online Library Full Collection 2019

Year:

Volume:

Issue:

Start Page:

Full text available via Wiley Online Library STM 2011

Year:

Volume:

Issue:

Start Page:

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Pfohl-Leszkowicz, A. "Further arguments in favour of direct covalent binding of Ochratoxin A (OTA) after metabolic biotransformation." Food additives and contaminants 22.s1 (2005): 75-87.
description	2.	Petrik, J. "Apoptosis and oxidative stress induced by ochratoxin A in rat kidney." Archives of toxicology 77.12 (2003): 685-693.
description	3.	Solfrizzo, M. "Simultaneous LC-MS/MS determination of aflatoxin M(1), ochratoxin A, deoxynivalenol, de-epoxydeoxynivalenol, alpha and beta-zearalenols and fumonisin B(1) in urine as a multi-biomarker method to assess exposure to mycotoxins." Analytical and bioanalytical chemistry 401.9 (2011): 2831-2841.
description	4.	Doorten, A. "Metabolism-mediated cytotoxicity of ochratoxin A." Toxicology in Vitro 18.3 (2004): 271-277.
description	5.	Mantle, P. "Renal tumourigenesis in male rats in response to chronic dietary ochratoxin A." Food additives and contaminants 22.SUPPL. 1 (2005): 58-64.
description	6.	Chen, N. "N-Acetylcysteine prevents ifosfamide-induced nephrotoxicity in rats." British journal of pharmacology 153.7 (2008): 1364-72.
description	7.	Krska, R. "Development and validation of a rapid multi-biomarker liquid chromatography/tandem mass spectrometry method to assess human exposure to mycotoxins." Rapid communications in mass spectrometry 26.13 (2012): 1533-1540.
description	8.	Ahn, J. "Quantitative determination of mycotoxins in urine by LC-MS/MS." Food Additives & Contaminants: Part A: Chemistry, Analysis, Control, Exposure & Risk Assessment 27.12 (2010): 1674-1682.
description	9.	O'Brien, E. "Ochratoxin A: The continuing enigma." Critical reviews in toxicology 35.1 (2005): 33-60.
description	10.	Ostry, V. "Raisins, ochratoxin A and human health." Mycotoxin research 18.2 (2002): 178-182.
description	11.	Amacher, David E. "The primary role of hepatic metabolism in idiosyncratic drug-induced liver injury." Expert Opinion on Drug Metabolism and Toxicology 8.3 (2012): 335-347.
description	12.	Yonke, Yongke u. "Effects of BSO and L-Cysteine on Drug-Induced Cytotoxicity in Primary Cell Cultures: Drug-, Cell Type-, and Species-Specific Difference." Drug and chemical toxicology 27.3 (2004): 269-80.
description	13.	Ringot, D. "Toxicokinetics and toxicodynamics of ochratoxin A, an update." Chemico-biological interactions 159.1 (2006): 18-46.
description	14.	Schaut, A. "Liquid chromatographic methods for biotransformation studies of ochratoxin A." Biomedical chromatography 22.9 (2008): 1013-1020.
description	15.	Knasmüller, S. "Structurally related mycotoxins ochratoxin A, ochratoxin B, and citrinin differ in their genotoxic activities and in their mode of action in human-derived liver (HepG2) cells: implications for risk assessment." Nutrition and cancer 50.2 (2004): 190-7.
description	16.	Yaseen Z, Michoudet C, Baverel G, Dubourg L, Z. "Mechanisms of the ifosfamide-induced inhibition of endocytosis in the rat proximal kidney tubule." Archives of toxicology 82.9: 607-614.
description	17.	D'Mello, J. "Fusarium mycotoxins: a review of global implications for animal health, welfare and productivity." Animal feed science and technology 80.3-4 (1999): 183-205.
description	18.	Caloni, F. "Aflatoxin M1 absorption and cytotoxicity on human intestinal in vitro model." Toxicon 47.4 (2006): 409-15.
description	19.	Turner, P. "Dietary wheat reduction decreases the level of urinary deoxynivalenol in UK adults." Journal of exposure science & environmental epidemiology 18.4: 392-9.
description	20.	Chen, N. "Prevention of ifosfamide nephrotoxicity by N-acetylcysteine: clinical pharmacokinetic considerations." The Canadian journal of clinical pharmacology 14.2 (2007): 246-50.